Viking Therapeutics, Inc. (VKTX)
35.18
-0.14
(-0.40%)
USD |
NASDAQ |
Dec 31, 16:00
35.01
-0.17
(-0.48%)
Pre-Market: 20:00
Viking Therapeutics Market Cap: 3.977B for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 961.86B |
| Pfizer Inc. | 141.57B |
| Amgen, Inc. | 176.25B |
| Altimmune, Inc. | 376.68M |
| Moderna, Inc. | 11.52B |
Market Cap Related Metrics
| PEG Ratio | -0.1317 |
| Price to Book Value | 5.577 |
| Price | 35.18 |
| Earnings Yield | -6.02% |
| PEGY Ratio | -0.1317 |